Literature DB >> 27330041

Multiple myeloma and family history of lymphohaematopoietic cancers: Results from the International Multiple Myeloma Consortium.

Leah H Schinasi1, Elizabeth E Brown2, Nicola J Camp3, Sophia S Wang4, Jonathan N Hofmann5, Brian C Chiu6, Lucia Miligi7, Laura E Beane Freeman5, Silvia de Sanjose8, Leslie Bernstein4, Alain Monnereau9,10, Jacqueline Clavel9,10, Guido J Tricot11, Djordje Atanackovic3, Pierluigi Cocco12, Laurent Orsi9,10, James A Dosman13, John R McLaughlin14, Mark P Purdue5, Wendy Cozen15, John J Spinelli16, Anneclaire J de Roos17.   

Abstract

Family clusters of multiple myeloma (MM) suggest disease heritability. Nevertheless, patterns of inheritance and the importance of genetic versus environmental risk factors in MM aetiology remain unclear. We pooled data from eleven case-control studies from the International Multiple Myeloma Consortium to characterize the association of MM risk with having a first-degree relative with a history of a lympho-haematapoietic cancer. Unconditional logistic regression models, adjusted for study, sex, age and education level, were used to estimate associations between MM risk and having a first-degree relative with a history of non-Hodgkin lymphoma, Hodgkin lymphoma, leukaemia or MM. Sex, African American race/ethnicity and age were explored as effect modifiers. A total of 2843 cases and 11 470 controls were included. MM risk was elevated in association with having a first-degree relative with any lympho-haematapoietic cancer (Odds Ratio (OR) = 1·29, 95% Confidence Interval (CI): 1·08-1·55). The association was particularly strong for having a first-degree relative with MM (OR = 1·90, 95% CI: 1·26-2·87), especially among men (OR = 4·13, 95% CI: 2·17-7·85) and African Americans (OR = 5·52, 95% CI: 1·87-16·27).These results support the hypothesis that genetic inheritance plays a role in MM aetiology. Future studies are warranted to characterize interactions of genetic markers with environmental exposures.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  epidemiology; family history; lympho-haematopoietic malignancies; lymphoma; multiple myeloma

Mesh:

Year:  2016        PMID: 27330041      PMCID: PMC5035512          DOI: 10.1111/bjh.14199

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  44 in total

Review 1.  Multiple myeloma: a review of the epidemiologic literature.

Authors:  Dominik D Alexander; Pamela J Mink; Hans-Olov Adami; Philip Cole; Jack S Mandel; Martin M Oken; Dimitrios Trichopoulos
Journal:  Int J Cancer       Date:  2007       Impact factor: 7.396

2.  Variation in innate immunity genes and risk of multiple myeloma.

Authors:  Mark P Purdue; Qing Lan; Idan Menashe; Tongzhang Zheng; Yawei Zhang; Meredith Yeager; H Dean Hosgood; Shelia H Zahm; Stephen J Chanock; Nathaniel Rothman; Dalsu Baris
Journal:  Hematol Oncol       Date:  2011-03       Impact factor: 5.271

3.  Use of hair coloring products and the risk of lymphoma, multiple myeloma, and chronic lymphocytic leukemia.

Authors:  S H Zahm; D D Weisenburger; P A Babbitt; R C Saal; J B Vaught; A Blair
Journal:  Am J Public Health       Date:  1992-07       Impact factor: 9.308

4.  Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance.

Authors:  Celine M Vachon; Robert A Kyle; Terry M Therneau; Barbara J Foreman; Dirk R Larson; Colin L Colby; Tara K Phelps; Angela Dispenzieri; Shaji K Kumar; Jerry A Katzmann; S Vincent Rajkumar
Journal:  Blood       Date:  2009-01-29       Impact factor: 22.113

5.  Association of a dominantly inherited hyperphosphorylated paraprotein target with sporadic and familial multiple myeloma and monoclonal gammopathy of undetermined significance: a case-control study.

Authors:  Sandra Grass; Klaus-Dieter Preuss; Manfred Ahlgrimm; Natalie Fadle; Evi Regitz; Claudia Pfoehler; Niels Murawski; Michael Pfreundschuh
Journal:  Lancet Oncol       Date:  2009-09-18       Impact factor: 41.316

6.  Familial occurrence of hematologic malignancies and other diseases in multiple myeloma: a case-control study.

Authors:  M Eriksson; B Hållberg
Journal:  Cancer Causes Control       Date:  1992-01       Impact factor: 2.506

7.  Occupational exposure to pesticides and lymphoid neoplasms among men: results of a French case-control study.

Authors:  L Orsi; L Delabre; A Monnereau; P Delval; C Berthou; P Fenaux; G Marit; P Soubeyran; F Huguet; N Milpied; M Leporrier; D Hemon; X Troussard; J Clavel
Journal:  Occup Environ Med       Date:  2008-11-18       Impact factor: 4.402

8.  Patterns of hematologic malignancies and solid tumors among 37,838 first-degree relatives of 13,896 patients with multiple myeloma in Sweden.

Authors:  Sigurdur Y Kristinsson; Magnus Björkholm; Lynn R Goldin; Cecilie Blimark; Ulf-Henrik Mellqvist; Anders Wahlin; Ingemar Turesson; Ola Landgren
Journal:  Int J Cancer       Date:  2009-11-01       Impact factor: 7.396

9.  Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk.

Authors:  Daniel Chubb; Niels Weinhold; Peter Broderick; Bowang Chen; David C Johnson; Asta Försti; Jayaram Vijayakrishnan; Gabriele Migliorini; Sara E Dobbins; Amy Holroyd; Dirk Hose; Brian A Walker; Faith E Davies; Walter A Gregory; Graham H Jackson; Julie A Irving; Guy Pratt; Chris Fegan; James Al Fenton; Kai Neben; Per Hoffmann; Markus M Nöthen; Thomas W Mühleisen; Lewin Eisele; Fiona M Ross; Christian Straka; Hermann Einsele; Christian Langer; Elisabeth Dörner; James M Allan; Anna Jauch; Gareth J Morgan; Kari Hemminki; Richard S Houlston; Hartmut Goldschmidt
Journal:  Nat Genet       Date:  2013-08-18       Impact factor: 38.330

10.  Family history of hematologic malignancies and risk of multiple myeloma: differences by race and clinical features.

Authors:  MaryAnn E VanValkenburg; Gwendolyn I Pruitt; Ilene K Brill; Luciano Costa; Maryam Ehtsham; Ian T Justement; Racquel D Innis-Shelton; Donna Salzman; E Shyam P Reddy; Kelly N Godby; Fady M Mikhail; Andrew J Carroll; Vishnu B Reddy; Ralph D Sanderson; Louis B Justement; Paul W Sanders; Elizabeth E Brown
Journal:  Cancer Causes Control       Date:  2015-11-23       Impact factor: 2.506

View more
  13 in total

1.  Computational Model of Progression to Multiple Myeloma Identifies Optimum Screening Strategies.

Authors:  Philipp M Altrock; Jeremy Ferlic; Tobias Galla; Michael H Tomasson; Franziska Michor
Journal:  JCO Clin Cancer Inform       Date:  2018-12

2.  Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study.

Authors:  Habib El-Khoury; David J Lee; Jean-Baptiste Alberge; Robert Redd; Christian J Cea-Curry; Jacqueline Perry; Hadley Barr; Ciara Murphy; Dhananjay Sakrikar; David Barnidge; Mark Bustoros; Houry Leblebjian; Anna Cowan; Maya I Davis; Julia Amstutz; Cody J Boehner; Elizabeth D Lightbody; Romanos Sklavenitis-Pistofidis; Mark C Perkins; Stephen Harding; Clifton C Mo; Prashant Kapoor; Joseph Mikhael; Ivan M Borrello; Rafael Fonseca; Scott T Weiss; Elizabeth Karlson; Lorenzo Trippa; Timothy R Rebbeck; Gad Getz; Catherine R Marinac; Irene M Ghobrial
Journal:  Lancet Haematol       Date:  2022-03-25       Impact factor: 30.153

3.  Germline Lysine-Specific Demethylase 1 (LSD1/KDM1A) Mutations Confer Susceptibility to Multiple Myeloma.

Authors:  Xiaomu Wei; M Nieves Calvo-Vidal; Siwei Chen; Gang Wu; Maria V Revuelta; Jian Sun; Jinghui Zhang; Michael F Walsh; Kim E Nichols; Vijai Joseph; Carrie Snyder; Celine M Vachon; James D McKay; Shu-Ping Wang; David S Jayabalan; Lauren M Jacobs; Dina Becirovic; Rosalie G Waller; Mykyta Artomov; Agnes Viale; Jayeshkumar Patel; Jude Phillip; Selina Chen-Kiang; Karen Curtin; Mohamed Salama; Djordje Atanackovic; Ruben Niesvizky; Ola Landgren; Susan L Slager; Lucy A Godley; Jane Churpek; Judy E Garber; Kenneth C Anderson; Mark J Daly; Robert G Roeder; Charles Dumontet; Henry T Lynch; Charles G Mullighan; Nicola J Camp; Kenneth Offit; Robert J Klein; Haiyuan Yu; Leandro Cerchietti; Steven M Lipkin
Journal:  Cancer Res       Date:  2018-03-20       Impact factor: 12.701

4.  Sequencing at lymphoid neoplasm susceptibility loci maps six myeloma risk genes.

Authors:  Rosalie Griffin Waller; Robert J Klein; Joseph Vijai; James D McKay; Alyssa Clay-Gilmour; Xiaomu Wei; Michael J Madsen; Douglas W Sborov; Karen Curtin; Susan L Slager; Kenneth Offit; Celine M Vachon; Steven M Lipkin; Charles Dumontet; Nicola J Camp
Journal:  Hum Mol Genet       Date:  2021-06-09       Impact factor: 6.150

5.  Circulating resistin levels and risk of multiple myeloma in three prospective cohorts.

Authors:  Loredana Santo; Lauren R Teras; Graham G Giles; Stephanie J Weinstein; Demetrius Albanes; Ye Wang; Ruth M Pfeiffer; Qing Lan; Nathaniel Rothman; Brenda M Birmann; Graham A Colditz; Michael N Pollak; Mark P Purdue; Jonathan N Hofmann
Journal:  Br J Cancer       Date:  2017-08-22       Impact factor: 7.640

6.  Dietary Pattern and Risk of Multiple Myeloma in Two Large Prospective US Cohort Studies.

Authors:  Dong Hoon Lee; Teresa T Fung; Fred K Tabung; Graham A Colditz; Irene M Ghobrial; Bernard A Rosner; Edward L Giovannucci; Brenda M Birmann
Journal:  JNCI Cancer Spectr       Date:  2019-04-27

Review 7.  Epidemiology, Staging, and Management of Multiple Myeloma.

Authors:  Sandeep Anand Padala; Adam Barsouk; Alexander Barsouk; Prashanth Rawla; Anusha Vakiti; Ravindra Kolhe; Vamsi Kota; Germame Hailegiorgis Ajebo
Journal:  Med Sci (Basel)       Date:  2021-01-20

Review 8.  Genome Instability in Multiple Myeloma: Facts and Factors.

Authors:  Anna Y Aksenova; Anna S Zhuk; Artem G Lada; Irina V Zotova; Elena I Stepchenkova; Ivan I Kostroma; Sergey V Gritsaev; Youri I Pavlov
Journal:  Cancers (Basel)       Date:  2021-11-26       Impact factor: 6.639

9.  Coinherited genetics of multiple myeloma and its precursor, monoclonal gammopathy of undetermined significance.

Authors:  Alyssa I Clay-Gilmour; Michelle A T Hildebrandt; Elizabeth E Brown; Jonathan N Hofmann; John J Spinelli; Graham G Giles; Wendy Cozen; Parveen Bhatti; Xifeng Wu; Rosalie G Waller; Alem A Belachew; Dennis P Robinson; Aaron D Norman; Jason P Sinnwell; Sonja I Berndt; S Vincent Rajkumar; Shaji K Kumar; Stephen J Chanock; Mitchell J Machiela; Roger L Milne; Susan L Slager; Nicola J Camp; Elad Ziv; Celine M Vachon
Journal:  Blood Adv       Date:  2020-06-23

10.  Novel pedigree analysis implicates DNA repair and chromatin remodeling in multiple myeloma risk.

Authors:  Rosalie G Waller; Todd M Darlington; Xiaomu Wei; Michael J Madsen; Alun Thomas; Karen Curtin; Hilary Coon; Venkatesh Rajamanickam; Justin Musinsky; David Jayabalan; Djordje Atanackovic; S Vincent Rajkumar; Shaji Kumar; Susan Slager; Mridu Middha; Perrine Galia; Delphine Demangel; Mohamed Salama; Vijai Joseph; James McKay; Kenneth Offit; Robert J Klein; Steven M Lipkin; Charles Dumontet; Celine M Vachon; Nicola J Camp
Journal:  PLoS Genet       Date:  2018-02-01       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.